Co-Authors
This is a "connection" page, showing publications co-authored by Charlotte Ulrik and Lars Pedersen.
Connection Strength
0.176
-
Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial. Eur Respir J. 2022 01; 59(1).
Score: 0.062
-
Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection: A cohort study. Int J Infect Dis. 2021 Jul; 108:370-376.
Score: 0.059
-
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 10; 21(1):513.
Score: 0.055